3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
6
Pancreatic Neoplasms
2
Lung Neoplasms
2
Gastrointestinal Neoplasms
2
Stomach Neoplasms
1
Sarcoma
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Multiple Myeloma
1
Mesothelioma, Malignant
1
Lymphoma
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cardiovascular Diseases
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Appendiceal Neoplasms
1
Interventions
Oxaliplatin
11
Mitomycin
11
Leucovorin
7
Hyperthermic Intraperitoneal Chemotherapy
7
Irinotecan
6
Fluorouracil
6
Cisplatin
4
Capecitabine
4
Surveys and Questionnaires
3
Doxorubicin
3
Cytoreduction Surgical Procedures
3
dehydroftorafur
2
Trastuzumab
2
Thalidomide
2
Mitozytrex
2
Melphalan
2
Interleukin-12 Subunit p35
2
Floxuridine
2
Drug Therapy
2
Cetuximab
2
Biopsy
2
tipifarnib
1
surufatinib
1
sodium thiosulfate
1
sintilimab
1
nintedanib
1
nilotinib
1
motexafin lutetium
1
irinotecan sucrosofate
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
Referral and Consultation
×
Gastrointestinal
×
Clear all
NCT01126346
2018-07-03
HOPE
Wake Forest University Health Sciences
Phase NA
Completed
10 enrolled